Swiss Life Holding Valuation
Is SLHN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SLHN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SLHN (CHF658.4) is trading below our estimate of fair value (CHF708.18)
Significantly Below Fair Value: SLHN is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SLHN?
Other financial metrics that can be useful for relative valuation.
What is SLHN's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CHF 18.97b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.4x |
Enterprise Value/EBITDA | 19.3x |
PEG Ratio | 4.2x |
Price to Earnings Ratio vs Peers
How does SLHN's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 20.1x | ||
SREN Swiss Re | 9.9x | 5.5% | CHF 32.5b |
BALN Bâloise Holding | 29.7x | 34.8% | CHF 7.1b |
HELN Helvetia Holding | 23x | 14.2% | CHF 6.4b |
ZURN Zurich Insurance Group | 17.7x | 9.2% | CHF 69.1b |
SLHN Swiss Life Holding | 17.5x | 4.2% | CHF 19.0b |
Price-To-Earnings vs Peers: SLHN is good value based on its Price-To-Earnings Ratio (17.5x) compared to the peer average (20.1x).
Price to Earnings Ratio vs Industry
How does SLHN's PE Ratio compare vs other companies in the European Insurance Industry?
Price-To-Earnings vs Industry: SLHN is expensive based on its Price-To-Earnings Ratio (17.5x) compared to the European Insurance industry average (10.8x).
Price to Earnings Ratio vs Fair Ratio
What is SLHN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 17.5x |
Fair PE Ratio | 16.2x |
Price-To-Earnings vs Fair Ratio: SLHN is expensive based on its Price-To-Earnings Ratio (17.5x) compared to the estimated Fair Price-To-Earnings Ratio (16.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 658.40 | CHF 630.13 -4.3% | 6.8% | CHF 693.00 | CHF 550.00 | n/a | 8 |
Jun ’25 | CHF 627.80 | CHF 629.88 +0.3% | 6.9% | CHF 693.00 | CHF 550.00 | n/a | 8 |
May ’25 | CHF 621.00 | CHF 628.50 +1.2% | 6.7% | CHF 690.00 | CHF 550.00 | n/a | 8 |
Apr ’25 | CHF 632.20 | CHF 627.63 -0.7% | 6.8% | CHF 690.00 | CHF 550.00 | n/a | 8 |
Mar ’25 | CHF 644.20 | CHF 623.94 -3.1% | 6.9% | CHF 690.00 | CHF 550.00 | n/a | 8 |
Feb ’25 | CHF 614.00 | CHF 624.94 +1.8% | 6.8% | CHF 690.00 | CHF 550.00 | n/a | 9 |
Jan ’25 | CHF 584.00 | CHF 604.48 +3.5% | 5.0% | CHF 653.00 | CHF 550.00 | n/a | 9 |
Dec ’24 | CHF 567.60 | CHF 600.92 +5.9% | 5.3% | CHF 653.00 | CHF 550.00 | n/a | 9 |
Nov ’24 | CHF 583.80 | CHF 599.46 +2.7% | 8.5% | CHF 653.00 | CHF 476.80 | n/a | 9 |
Oct ’24 | CHF 571.60 | CHF 600.90 +5.1% | 8.6% | CHF 653.00 | CHF 476.80 | n/a | 9 |
Sep ’24 | CHF 555.80 | CHF 594.01 +6.9% | 8.4% | CHF 653.00 | CHF 476.80 | n/a | 9 |
Aug ’24 | CHF 552.80 | CHF 597.61 +8.1% | 8.1% | CHF 653.00 | CHF 476.80 | n/a | 10 |
Jul ’24 | CHF 523.00 | CHF 593.68 +13.5% | 7.9% | CHF 633.00 | CHF 476.80 | n/a | 9 |
Jun ’24 | CHF 529.40 | CHF 593.70 +12.1% | 7.9% | CHF 633.00 | CHF 477.00 | CHF 627.80 | 9 |
May ’24 | CHF 586.80 | CHF 597.21 +1.8% | 9.3% | CHF 701.00 | CHF 477.00 | CHF 621.00 | 10 |
Apr ’24 | CHF 563.20 | CHF 589.01 +4.6% | 7.5% | CHF 630.00 | CHF 477.00 | CHF 632.20 | 10 |
Mar ’24 | CHF 586.40 | CHF 561.35 -4.3% | 8.3% | CHF 624.00 | CHF 477.00 | CHF 644.20 | 9 |
Feb ’24 | CHF 541.40 | CHF 554.68 +2.5% | 8.1% | CHF 624.00 | CHF 477.00 | CHF 614.00 | 9 |
Jan ’24 | CHF 476.80 | CHF 552.80 +15.9% | 8.1% | CHF 624.00 | CHF 477.00 | CHF 584.00 | 9 |
Dec ’23 | CHF 511.00 | CHF 552.77 +8.2% | 8.1% | CHF 624.00 | CHF 476.80 | CHF 567.60 | 9 |
Nov ’23 | CHF 483.40 | CHF 556.88 +15.2% | 9.0% | CHF 650.00 | CHF 476.80 | CHF 583.80 | 9 |
Oct ’23 | CHF 438.50 | CHF 566.72 +29.2% | 9.1% | CHF 650.00 | CHF 476.80 | CHF 571.60 | 9 |
Sep ’23 | CHF 499.00 | CHF 564.55 +13.1% | 8.8% | CHF 650.00 | CHF 476.80 | CHF 555.80 | 10 |
Aug ’23 | CHF 502.80 | CHF 554.74 +10.3% | 7.9% | CHF 635.00 | CHF 485.00 | CHF 552.80 | 9 |
Jul ’23 | CHF 463.90 | CHF 583.34 +25.7% | 8.8% | CHF 659.00 | CHF 465.00 | CHF 523.00 | 9 |
Jun ’23 | CHF 541.40 | CHF 594.90 +9.9% | 8.7% | CHF 659.00 | CHF 465.00 | CHF 529.40 | 9 |
Analyst Forecast: Target price is lower than the current share price.